They are related, because better recovery lets you train more consistently, but the peptides that serve each goal work through completely different mechanisms
Discovery and design of exosite inhibitors
Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: Results from two randomized, double-blind, placebo-controlled studies with single oral doses
Individuals using GLP-1 treatments, such as those in programs like Tyde Wellness, report an average body weight reduction of 15% after 68 weeks, with many achieving weight loss of over 20-25% within a year
Protocols are personalized based on goals, baseline lifestyle load, skin concerns and response